Sai Life Sciences Profit & Loss Annual

BSE: 544306 | NSE: SAILIFE | ISIN: INE570L01029 | Sector: Biotechnology & Drugs

1,366.05 -49.20 (-3.48%)Updated : 07 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	1,736.19	1,425.67	1,299.13	1,151.07
Other Net	49.13	-0.03	0.69	-3.76
Diluted Weighted Average Shares	21.24	19.76	20.80	20.80
Depreciation/ Amortization	166.86	138.57	119.44	99.43
Operating Income	456.30	268.90	166.05	66.07
Net Income	348.91	170.13	82.81	9.99
Income Availableto Com Excl Extra Ord	348.91	170.13	82.81	9.99
Other Operating Expenses Total	307.39	0.13	0.30	1.06
Net Income Before Taxes	466.19	227.70	109.23	16.41
Net Income After Taxes	348.91	170.13	82.81	9.99
Income Availableto Com Incl Extra Ord	348.91	170.13	82.81	9.99
Costof Revenue Total	570.89	558.87	539.25	505.21
Gross Profit	1,621.60	1,135.70	925.93	711.93
Interest Inc( Exp) Net- Non- Op Total	-39.24	-39.35	-57.52	-45.34
Unusual Expense( Income)	8.00	1.72	-	-
Diluted Net Income	348.91	170.13	82.81	9.99
Provisionfor Income Taxes	117.28	57.57	26.43	6.42
period Type	-	-	-	-
Net Income Before Extra Items	348.91	170.13	82.81	9.99
Total Revenue	2,192.49	1,694.57	1,465.18	1,217.14
period Length	12.00	12.00	12.00	12.00
Revenue	2,192.49	1,694.57	1,465.18	1,217.14
Selling/ General/ Admin Expenses Total	683.06	726.38	640.14	545.38
Diluted Normalized EPS	16.71	8.74	3.98	0.50
Diluted EPS Excluding Extra Ord Items	16.43	8.61	3.98	0.48
Gain( Loss)on Saleof Assets	-	-1.81	0.01	-0.57

*All figures in crores except per share values

Trending Stocks

2,427.00+57.00(2.41%)

1,653.95+18.95(1.16%)

3,443.60+28.60(0.84%)

1,093.40-56.50 (-4.91%)

2,007.00-82.25 (-3.94%)

Related News